Pharmafile Logo
Pharmafocus logo
Advanced Search

biotech

Showing 15 posts of 841 posts found.

handshake_2

Vifor Fresenius snap up rights to Cara’s itch therapy

May 23, 2018
Research and Development, Sales and Marketing Cara Therapeutics, Vifor Fresenius, biotech, drugs, pharma, pharmaceutical

The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and …

News
obese-3011213_960_720

World heading towards 25% of total population being obese

May 23, 2018
Research and Development WHO, biotech, drugs, obesity, pharma, pharmaceutical

The latest global research paints a bleak picture of future global public health, predicting that almost a quarter of the …

News
takeda_tokyo_hq

Takeda begins to shore up finances with $280m divestment

May 23, 2018
Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Much has already been written about Takeda and its massive financial stretch to pull in the Shire acquisition, in the …

News

NHS Trust harnesses AI to speed up treatment

May 22, 2018
Manufacturing and Production, Medical Communications AI, NHS, biotech, drugs, pharma, pharmaceutical

The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …

News
brothers-457237_960_720

The cause of the most common form of childhood cancer found

May 22, 2018
Manufacturing and Production, Research and Development biotech, drugs, leukaemia, pharma, pharmaceutical

Professor Mel Greaves, of The Institute of Cancer Research, has spent 30 years uncovering what is behind the mysterious rise …

News
pills_shot

Nabriva closes in on bringing new class of antibiotic to market

May 22, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical

Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could …

News
gilead-sciences

Gilead expands operations in Cork, Ireland

May 21, 2018
Manufacturing and Production, Sales and Marketing Gilead, Ireland, biotech, drugs, pharma, pharmaceutical

Gilead has unveiled the expansion of its Cork manufacturing site, involved in the creation of its treatments for HIV and …

News
roche

Roche’s Hemlibra stakes claim to be haemophilia market leader

May 21, 2018
Research and Development, Sales and Marketing Hemlibra, Roche, Shire, biotech, drugs, haemophilia, pharma, pharmaceutical

Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only …

News
greek_parliament

Investigation of kickbacks in Greece sputters to halt

May 21, 2018
Sales and Marketing Greece, Novartis, biotech, drugs, pharma, pharmaceutical

Greek parliament has decided against investigating allegations of bribery, involving Novartis and numerous high-level former politicians. The case has dominated …

News
ebola

Ebola threat intensifies in DR Congo

May 18, 2018
Medical Communications Ebola, MSD, biotech, drugs, pharma, pharmaceutical

The Ebola outbreak in the Democratic Republic of Congo is becoming increasingly serious, after it was confirmed that there was …

News
headache

Amgen/Novartis potential blockbuster migraine med gets FDA nod

May 18, 2018
Medical Communications, Sales and Marketing Allergan, Amgen, Novartis, biotech, drugs, migraine, pharma, pharmaceutical

The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig …

News

Study finds Herceptin use can be halved

May 17, 2018
Medical Communications, Research and Development Herceptin, Roche, biosimilars, biotech, drugs, pharma, pharmaceutical

A team of researchers from the University of Cambridge and Warwick Clinical Trials have revealed that Roche’s Herceptin is just …

News

Ipsen receives European first-line approval for Cabometyx

May 17, 2018
Sales and Marketing Cabometyx, biotech, drugs, ipsen, pharma, pharmaceutical

Ipsen has revealed that it has received approval for the use of Cabometyx for first-line use in patients with advanced …

News
brexit_flag_0

UK MPs call for Brexit priority over pharma industry

May 17, 2018
Medical Communications ABPI, UK government, biotech, drugs, pharma, pharmaceutical

A new report published by the Business, Energy and Industrial Strategy Committee has called for the UK government to ensure …

News
roche_close

Roche gets NICE approval for advanced bladder cancer

May 17, 2018
Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical, tecentriq

Though trial results for Tecentriq (atezolizumab) may not necessarily be going Roche’s way, after a combination treatment failure, the treatment …

News

Latest content

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023

FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023